SIMBRINZA (Alcon Laboratories, Inc.)
Welcome to the PulseAid listing for the SIMBRINZA drug offered from Alcon Laboratories, Inc.. This Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alcon Laboratories, Inc. |
| NON-PROPRIETARY NAME: | brinzolamide/brimonidine tartrate |
| SUBSTANCE NAME: | BRINZOLAMIDE; BRIMONIDINE TARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SUSPENSION/ DROPS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-05-01 |
| END MARKETING DATE: | 0000-00-00 |
SIMBRINZA HUMAN PRESCRIPTION DRUG Details:
| Item Description | SIMBRINZA from Alcon Laboratories, Inc. |
| LABELER NAME: | Alcon Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10; 2(mg/mL; mg/mL) |
| START MARKETING DATE: | 2013-05-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0065-4147_89b65445-ed36-ade4-99a4-d84c40eb0078 |
| PRODUCT NDC: | 0065-4147 |
| APPLICATION NUMBER: | NDA204251 |
Other BRINZOLAMIDE; BRIMONIDINE TARTRATE Pharmaceutical Manufacturers / Labelers:
